Neogen (NEOG) Cash from Investing Activities (2010 - 2026)

Neogen (NEOG) recorded quarterly Cash from Investing Activities of -$11.6 million in Q1 2026, up 0.97% quarter-over-quarter from -$11.7 million in Q4 2025, and up 64.42% on a YoY basis from -$7.0 million in Q1 2025.

Neogen (NEOG) Cash from Investing Activities (2010 - 2026) Analysis & Trends

Neogen's Cash from Investing Activities history runs 17 years deep, the most recent figure standing at -$11.6 million for Q1 2026.

  • In Q1 2026, Cash from Investing Activities rose 64.42% year-over-year to -$11.6 million; the TTM figure through Feb 2026 stood at $58.6 million (up 158.13% YoY), while the FY2025 annual figure was -$99.2 million, down 238.45% from the prior year.
  • Cash from Investing Activities was -$11.6 million for Q1 2026 at Neogen, up from -$11.7 million in the prior quarter.
  • In the past five years, Cash from Investing Activities ranged from a high of $97.7 million in Q3 2025 to a low of -$33.7 million in Q3 2024.
  • Historically, Cash from Investing Activities has averaged $6.7 million across 5 years, with a median of -$11.7 million in 2025.
  • The sharpest annual moves came in 2022 and 2024: Cash from Investing Activities surged 421.32% in 2022, then sank 354.84% in 2024.
  • A 5-year view of Cash from Investing Activities shows it stood at $93.0 million in 2022, then sank by 87.6% to $11.5 million in 2023, then tumbled by 248.73% to -$17.2 million in 2024, then surged by 31.99% to -$11.7 million in 2025, then increased by 0.97% to -$11.6 million in 2026.
  • The last three Cash from Investing Activities figures came in at -$11.6 million (Q1 2026), -$11.7 million (Q4 2025), and $97.7 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Investing Activities (Qtr)
1 Abbott Laboratories 152.92 Bn 146.27 Bn 6.27 Bn -20.32 Bn
2 Stryker 119.50 Bn 116.62 Bn 3.81 Bn -185.00 Mn
3 Medtronic 102.71 Bn 94.54 Bn 5.76 Bn -816.00 Mn
4 Boston Scientific 69.72 Bn 68.51 Bn 3.61 Bn -591.00 Mn
5 Edwards Lifesciences 49.24 Bn 45.57 Bn 1.29 Bn -92.80 Mn
6 GE HealthCare Technologies 29.74 Bn 27.67 Bn 1.98 Bn -2.50 Bn
7 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn -475.32 Mn
8 Dexcom 28.96 Bn 27.84 Bn 750.30 Mn -298.50 Mn
9 Steris 20.31 Bn 19.88 Bn 697.10 Mn -217.20 Mn
10 Neogen 1.98 Bn 1.82 Bn 99.00 Mn -11.56 Mn

Historic Data

Download Data
DateValue
Feb 28, 2026 -11.56 Mn
Feb 28, 2026 -11.56 Mn
Nov 30, 2025 -11.67 Mn
Nov 30, 2025 -11.67 Mn
Aug 31, 2025 97.73 Mn
Aug 31, 2025 97.73 Mn
May 31, 2025 -15.90 Mn
May 31, 2025 -15.90 Mn
Feb 28, 2025 -32.48 Mn
Feb 28, 2025 -32.48 Mn
Nov 30, 2024 -17.16 Mn
Nov 30, 2024 -17.16 Mn
Aug 31, 2024 -33.66 Mn
Aug 31, 2024 -33.66 Mn
May 31, 2024 -17.52 Mn
May 31, 2024 -17.52 Mn
Feb 29, 2024 -14.64 Mn
Feb 29, 2024 -14.64 Mn
Nov 30, 2023 11.54 Mn
Nov 30, 2023 11.54 Mn